{"id":"W3138851413","doi":"10.1016/j.esmoop.2021.100089","title":"An analysis of health-related quality of life in the phase III PROSELICA and FIRSTANA studies assessing cabazitaxel in patients with metastatic castration-resistant prostate cancer","year":2021,"lang":"en","type":"article","venue":"ESMO Open","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Janssen Pharmaceuticals; Merck Sharp and Dohme; Johnson and Johnson; Genentech; Astellas Pharma; Roche; National Institute for Health and Care Research; Novartis; Sanofi; GlaxoSmithKline; Merck; Bayer; AstraZeneca; Amgen; Pfizer","keywords":"Cabazitaxel; Docetaxel; Medicine; Prostate cancer; Quality of life (healthcare); Internal medicine; Oncology; Cancer; Chemotherapy; Androgen deprivation therapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01057019,0.0006671469,0.001720576,0.0009926613,0.0004657031,0.001104095,0.0006100511,0.0005910495,0.002686694],"category_scores_gemma":[0.008475396,0.0003014602,0.004778593,0.001503261,0.0004491018,0.0007057001,0.0008863152,0.001605319,0.0002173508],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009122613,"about_ca_system_score_gemma":0.001393713,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001045377,"about_ca_topic_score_gemma":0.00388044,"domain_scores_codex":[0.9940025,0.003825219,0.0006051559,0.0005012628,0.0007305158,0.000335278],"domain_scores_gemma":[0.9912962,0.00351007,0.002873162,0.000620586,0.0009556576,0.0007443982],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5467036,0.004933914,0.283708,0.008693553,0.05205842,0.000212981,0.0004847649,0.004103493,0.004839549,0.0009410416,0.01190574,0.08141492],"study_design_scores_gemma":[0.1038359,0.0716611,0.7657623,0.001370056,0.02753281,0.0006568151,0.0004680311,0.003009412,0.002633431,0.0006438983,0.02226616,0.0001601783],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9568703,0.02280818,0.0007796771,0.0006935723,0.0001454421,0.001800056,0.01444611,0.00002634207,0.002430287],"genre_scores_gemma":[0.9776686,0.00246803,0.0009729754,0.0005019965,0.0001002425,0.002370314,0.01524112,0.00001446115,0.0006623825],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01057019,"threshold_uncertainty_score":0.05590123,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1488546624960271,"score_gpt":0.4834998996692597,"score_spread":0.3346452371732326,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}